![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 49, 34669-34675, December 3, 1999
,
§
From the We previously demonstrated that
lysophosphatidylcholine up-regulated endothelial nitric-oxide synthase
promoter activity by increasing Sp1 binding via the action of protein
serine/threonine phosphatase 2A (Cieslik, K., Zembowicz, A., Tang,
J.-L., and Wu, K.K. (1998) J. Biol. Chem. 273, 14885-14890). To characterize the regulation of basal endothelial
nitric-oxide synthase promoter activity and the signaling pathway
through which lysophosphatidylcholine augments endothelial nitric-oxide
synthase transcription, we used a casein kinase 2 inhibitor coupled
with immunoprecipitation to demonstrate that basal Sp1 binding and
endothelial nitric-oxide synthase promoter activity were controlled by
casein kinase 2 complexed with protein serine/threonine phosphatase 2A.
Casein kinase 2 catalyzed protein serine/threonine
phosphatase 2A phosphorylation thereby inhibiting its
activity. Lysophosphatidylcholine selectively activated p42/p44
mitogen-activated protein kinase. Purified extracellular regulated kinase 2 blocked casein kinase 2 activity and
increased protein serine/threonine phosphatase 2A activity, resulting
in an increased Sp1 binding and endothelial nitric-oxide synthase promoter activity. These results indicate that Sp1 binding to its
cognate site on the endothelial nitric-oxide synthase promoter and its
transactivation of endothelial nitric-oxide synthase is regulated
by post-translational Sp1 phosphorylation and dephosphorylation through
a dynamic interaction between casein kinase 2 and protein serine/threonine phosphatase 2A.
Vascular Biology Research Center and
Division of Hematology, University of Texas-Houston Medical School,
Houston, Texas 77030 and the § Vascular Biology Program,
Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan and
National Taiwan University Hospital, College of Medicine,
Taipei, Taiwan 115
This article has been cited by other articles:
![]() |
V. Bartella, S. Cascio, E. Fiorio, A. Auriemma, A. Russo, and E. Surmacz Insulin-Dependent Leptin Expression in Breast Cancer Cells Cancer Res., June 15, 2008; 68(12): 4919 - 4927. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Brunelli, K. A. Cieslik, J. L. Alcorn, M. Vatta, and A. Baldini Peroxisome Proliferator-Activated Receptor-{delta} Upregulates 14-3-3{epsilon} in Human Endothelial Cells via CCAAT/Enhancer Binding Protein-{beta} Circ. Res., March 16, 2007; 100(5): e59 - e71. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Searles Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression Am J Physiol Cell Physiol, November 1, 2006; 291(5): C803 - C816. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schulz and G. Heusch Connexin 43 and ischemic preconditioning Cardiovasc Res, May 1, 2004; 62(2): 335 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Greif, D. B. Sacks, and T. Michel Calmodulin phosphorylation and modulation of endothelial nitric oxide synthase catalysis PNAS, February 3, 2004; 101(5): 1165 - 1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saura, C. Zaragoza, W. Cao, C. Bao, M. Rodriguez-Puyol, D. Rodriguez-Puyol, and C. J. Lowenstein Smad2 Mediates Transforming Growth Factor-{beta} Induction of Endothelial Nitric Oxide Synthase Expression Circ. Res., November 1, 2002; 91(9): 806 - 813. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kohlstedt, F. Shoghi, W. Muller-Esterl, R. Busse, and I. Fleming CK2 Phosphorylates the Angiotensin-Converting Enzyme and Regulates Its Retention in the Endothelial Cell Plasma Membrane Circ. Res., October 18, 2002; 91(8): 749 - 756. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. WU Regulation of Endothelial Nitric Oxide Synthase Activity and Gene Expression Ann. N.Y. Acad. Sci., May 1, 2002; 962(1): 122 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C Kone Molecular biology of natriuretic peptides and nitric oxide synthases Cardiovasc Res, August 15, 2001; 51(3): 429 - 441. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Morimoto, N. Kume, S. Miyamoto, Y. Ueno, H. Kataoka, M. Minami, K. Hayashida, N. Hashimoto, and T. Kita Lysophosphatidylcholine Induces Early Growth Response Factor-1 Expression and Activates the Core Promoter of PDGF-A Chain in Vascular Endothelial Cells Arterioscler. Thromb. Vasc. Biol., May 1, 2001; 21(5): 771 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Govers and T. J. Rabelink Cellular regulation of endothelial nitric oxide synthase Am J Physiol Renal Physiol, February 1, 2001; 280(2): F193 - F206. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. DiCorleto Protein Tyrosine Phosphatases in the Vessel Wall : Counterpoint to the Tyrosine Kinases Arterioscler. Thromb. Vasc. Biol., May 1, 2000; 20(5): 1179 - 1181. [Full Text] [PDF] |
||||
![]() |
K. Cieslik, C. S. Abrams, and K. K. Wu Up-regulation of Endothelial Nitric-oxide Synthase Promoter by the Phosphatidylinositol 3-Kinase gamma /Janus Kinase 2/MEK-1-dependent Pathway J. Biol. Chem., January 5, 2001; 276(2): 1211 - 1219. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |